Literature DB >> 29164596

Regulation of T helper cell responses during antigen presentation by norepinephrine-exposed endothelial cells.

Linghui Xu1, Wanhong Ding1, Lori L Stohl1, Xi K Zhou2, Shayan Azizi1, Ethan Chuang1, Jimmy Lam1, John A Wagner3,4, Richard D Granstein1.   

Abstract

Dermal blood vessels and regional lymph nodes are innervated by sympathetic nerves and, under stress, sympathetic nerves release norepinephrine (NE). Exposure of primary murine dermal microvascular endothelial cells (pDMECs) to NE followed by co-culture with Langerhans cells (LCs), responsive CD4+ T-cells and antigen resulted in modulation of CD4+ T-cell responses. NE-treatment of pDMECs induced increased production of interleukin (IL)-6 and IL-17A while down-regulating interferon (IFN)-γ and IL-22 release. This effect did not require contact between pDMECs and LCs or T-cells and depended upon pDMEC production of IL-6. The presence of NE-treated pDMECs increased the proportion of CD4+ T-cells expressing intracellular IL-17A and increased IL-17A mRNA while decreasing the proportion of IFN-γ- or IL-22-expressing CD4+ T-cells and mRNA levels for those cytokines. Retinoic acid receptor-related orphan receptor gamma (ROR-γt) mRNA was significantly increased in CD4+ T-cells while T-box transcription factor (T-bet) mRNA was decreased. Intradermal administration of NE prior to hapten immunization at the injection site produced a similar bias in draining lymph node CD4+ T-cells towards IL-17A and away from IFN-γ and IL-22 production. Under stress, release of NE may have significant regulatory effects on the outcome of antigen presentation through actions on ECs with enhancement of inflammatory skin disorders involving IL-17/T helper type 17 (Th17) cells.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell; antigen-presenting cells; cytokines; dendritic cells; endothelial cells

Mesh:

Substances:

Year:  2017        PMID: 29164596      PMCID: PMC5904699          DOI: 10.1111/imm.12871

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  68 in total

1.  Neuroendocrine regulation of immunity.

Authors:  Jeanette I Webster; Leonardo Tonelli; Esther M Sternberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  High density of beta 2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT).

Authors:  V Steinkraus; C Körner; M Steinfath; H Mensing
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 4.  Effects of stress on the immune system.

Authors:  D N Khansari; A J Murgo; R E Faith
Journal:  Immunol Today       Date:  1990-05

5.  Remission of psoriasis associated with cutaneous nerve section.

Authors:  S B Dewing
Journal:  Arch Dermatol       Date:  1971-08

6.  Regulation of beta-adrenergic receptors on endothelial cells in culture.

Authors:  K Graf; M Gräfe; U Dümmler; A O'Connor; V Regitz-Zagrosek; G Kunkel; W Auch-Schwelk; E Fleck
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

7.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 8.  Antigen presentation by Langerhans cells.

Authors:  Botond Z Igyártó; Daniel H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-12-12       Impact factor: 7.486

9.  CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activation.

Authors:  Wanhong Ding; John A Wagner; Richard D Granstein
Journal:  J Invest Dermatol       Date:  2007-05-10       Impact factor: 8.551

10.  Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.

Authors:  A Asahina; J Hosoi; S Beissert; A Stratigos; R D Granstein
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

View more
  4 in total

1.  T cell addiction: can pathogenic T cells be controlled using dopamine receptors?

Authors:  Kym A Bain; Simon Milling
Journal:  Immunology       Date:  2019-11       Impact factor: 7.397

Review 2.  Beta2-Adrenoceptor Agonists in Parkinson's Disease and Other Synucleinopathies.

Authors:  Luca Magistrelli; Cristoforo Comi
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-07       Impact factor: 4.147

Review 3.  Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target.

Authors:  Gwendolyn K Davis; Daniel J Fehrenbach; Meena S Madhur
Journal:  Curr Hypertens Rep       Date:  2021-03-05       Impact factor: 5.369

Review 4.  α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.

Authors:  Laura M Butkovich; Madelyn C Houser; Malú G Tansey
Journal:  Front Neurosci       Date:  2018-09-11       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.